Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer
about
Maximising the potential of AKT inhibitors as anti-cancer treatmentsRadiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors.Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer.AKT/PKB Signaling: Navigating the Network.Protein Kinase Targets in Breast Cancer.Phosphorylation-Dependent Inhibition of Akt1
P2860
Q28072254-1BE8BDCB-5960-4BAA-B589-A9F5D60AD92BQ36348567-F8B6EA7B-3827-43DA-956A-CEEABFCA8919Q38715635-3D8DA8E3-A061-4EF4-BFAD-908C6C86E1C4Q38825945-8FE43B3A-2665-447B-B921-048370007226Q39255027-D5FAB028-6B70-465D-970B-7C7510366651Q47351355-F2A341AE-1592-4F14-A0A9-88F8A4D4B2D2Q58758462-0CDA1EAE-2AD3-4801-AB1A-AFE71F046E1A
P2860
Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Phase I Study of an AKT Inhibi ...... n Advanced HER2+ Breast Cancer
@en
type
label
Phase I Study of an AKT Inhibi ...... n Advanced HER2+ Breast Cancer
@en
prefLabel
Phase I Study of an AKT Inhibi ...... n Advanced HER2+ Breast Cancer
@en
P2093
P2860
P1476
Phase I Study of an AKT Inhibi ...... n Advanced HER2+ Breast Cancer
@en
P2093
Amye J Tevaarwerk
Christopher Flynn
Jens Eickhoff
Jill M Kolesar
Kari B Wisinski
Maria C Bell
Mark E Burkard
Murtuza Rampurwala
P2860
P304
P356
10.1158/1078-0432.CCR-15-2365
P407
P577
2016-03-29T00:00:00Z